Clinical trials · Pennsylvania
Hidradenitis Suppurativa clinical trials in Pennsylvania
We’re tracking 7 recruiting hidradenitis suppurativa studies with a site in Pennsylvania — including Phase 1, Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Pennsylvania
- NCT07049575RecruitingPhase 1
Ruxolitinib cream study for hidradenitis suppurativa
This study tests a cream called ruxolitinib for people with hidradenitis suppurativa (HS). The goal is to see how much of the cream is absorbed when it's applied to a large area of the body.
Philadelphia, PennsylvaniaAges 12–75 - NCT07287644RecruitingPhase 2/Phase 3
Study of BFB759 for moderate to severe hidradenitis suppurativa
This trial tests a new medication, BFB759, to see if it can help people with moderate to severe hidradenitis suppurativa (a skin condition that causes painful bumps and abscesses) when antibiotics haven't worked well enough. It is designed for adults whose symptoms are not well controlled with current treatments.
Pittsburgh, PennsylvaniaAges 18–75 - NCT07213973RecruitingPhase 2
Study of povorcitinib for teens with hidradenitis suppurativa
This trial tests an oral medication called povorcitinib for adolescents aged 12–17 with moderate to severe hidradenitis suppurativa (HS) that hasn't improved with standard treatments like antibiotics. It aims to see how well the drug works and if it's safe.
Danville, PennsylvaniaAges 12–17 - NCT07414550Recruiting
Radiation therapy for hard-to-treat hidradenitis suppurativa
This trial tests if low-dose radiation therapy can help people with moderate to severe hidradenitis suppurativa (HS) that hasn't gotten better with other treatments. It's for those with sores in both armpits.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07748169Recruiting
Observational study of skin disease patients
This study looks at the health records of people with skin diseases to learn more about their care and outcomes. It may help improve future treatments.
Philadelphia, PennsylvaniaAges Any age - NCT06855498RecruitingPhase 3
Rollover study for patients who took povorcitinib before
This study is for people who have already taken the study drug povorcitinib in a previous trial and found it helpful. It lets you continue receiving the treatment and allows doctors to keep tracking its long-term safety and effects.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05243966Recruiting
Registry for soft tissue repair using a special matrix
This study is a registry that collects information from people who had soft tissue repair using a specific matrix and/or morcell material. It may help researchers understand how this approach performs in real-world care and patient outcomes over time.
Lancaster, PennsylvaniaAges 18 years+
Hidradenitis Suppurativa trials by city in Pennsylvania
Where these studies are running in Pennsylvania
Institutions with a site for the recruiting hidradenitis suppurativa studies listed above.
- Geisinger Medical Center
- Investigative Site US
- Investigative Site US069
- Lancaster General Hospital
- Paddington Testing Company
- Reading Hospital
- Thomas Jefferson University Hospital
- University of Pennsylvania
What taking part in a hidradenitis suppurativa study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Hidradenitis Suppurativa trials in other states
Common questions
- Are there hidradenitis suppurativa clinical trials in Pennsylvania?
- Yes. We're currently tracking 7 recruiting hidradenitis suppurativa studies with a site in Pennsylvania, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hidradenitis suppurativa study in Pennsylvania?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Pennsylvania to take part?
- Not necessarily. These studies have a site in Pennsylvania, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hidradenitis suppurativa trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hidradenitis suppurativa studies open in Pennsylvania regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.